Total medical devices venture financing deals worth $672.71m were announced in the United States during January 2019, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 42.8% over the previous month and a rise of 24% when compared with the last 12-month average of $542.36m.
The United States held a 68.9% share of the global medical devices venture financing deal value that touched $975.94m in January 2019.
In terms of deal activity, the United States recorded 54 deals during January 2019, marking an increase of 10.2% over the previous month and a rise of 12.5% over the 12-month average.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedical devices venture financing deals for January 2019: Top deals
The top five medical devices venture financing deals accounted for 37.9% of the overall value in the sector globally during January 2019.
The combined value of the top five medical devices venture financing deals stood at $255m, against the overall value of $672.71m recorded for the month. The top announced medical devices venture financing deal tracked by GlobalData in January 2019 was Michigan Accelerator Fund I and Novus Biotechnology Fund 1’s $77m venture financing of Ablative Solutions.
In second place was Abingworth Management, Endeavour Vision, HBM Partners, HealthCrest, Hercules Capital, Interwest Partners’ venture financing of Gynesonics for $75m and in third place was Deerfield Management and Seroba Life Sciences’ $45m venture financing of PQ Bypass.
General Catalyst Partners’ $31m venture financing of Mindstrong and Westwood Management’s venture financing of JustRight Surgical for $27m held fourth and fifth positions, respectively.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
Verdict’s parent company GlobalData plc provides business information to 4,000 of the world’s largest companies.
